Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–3 of 3 results
Advanced filters: Author: Capucine Penicaud Clear advanced filters

  • The development of effective antiretroviral therapies has greatly improved the disease prognosis for patients with HIV. However, the limitations of these therapies have renewed interest in developing alternative treatment strategies. Here, a group of experts from the International AIDS Society discuss the research steps that need to be taken to achieve the ultimate objective — a cure for HIV.

    • Steven G. Deeks
    • Brigitte Autran
    • Françoise Barré-Sinoussi
    Reviews
    Nature Reviews Immunology
    Volume: 12, P: 607-614

  • More than 250 million people worldwide are chronically infected with the hepatitis B virus (HBV). In this Comment, members of the International Coalition to Eliminate HBV appraise the current policy environment and the need for appropriate cure research and preparedness to complement the WHO global elimination strategy, the HBV vaccine and the well-tolerated but poorly accessed therapy.

    • Jeffrey V. Lazarus
    • Timothy Block
    • Benjamin C. Cowie
    Comments & Opinion
    Nature Reviews Gastroenterology & Hepatology
    Volume: 15, P: 517-518

  • Currently, there is no cure for hepatitis B virus (HBV) infection, which can lead to chronic liver disease and liver cancer, and only a few biomarkers are available. This Roadmap provides an overview of HBV serum biomarkers and their challenges.

    • Anna Kramvis
    • Kyong-Mi Chang
    • Peter A. Revill
    Reviews
    Nature Reviews Gastroenterology & Hepatology
    Volume: 19, P: 727-745